Learning Objectives:

• Understand molecular basis for hemoglobin switching
• Understand mechanisms for FDA approved gene therapies for sickle cell disease
• Understand the patient flow for gene therapy

Session date: 
01/29/2024 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. James LaBelle